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Abstract In clinical practice, it is very useful to select an optimal cutpoint in the scale of a continuous
biomarker or diagnostic test for classifying individuals as healthy or diseased. Several methods for
choosing optimal cutpoints have been presented in the literature, depending on the ultimate goal. One
of these methods, the generalized symmetry point, recently introduced, generalizes the symmetry
point by incorporating the misclassification costs. Two statistical approaches have been proposed in the
literature for estimating this optimal cutpoint and its associated sensitivity and specificity measures,
a parametric method based on the generalized pivotal quantity and a nonparametric method based
on empirical likelihood. In this paper, we introduce GsymPoint, an R package that implements these
methods in a user-friendly environment, allowing the end-user to calculate the generalized symmetry
point depending on the levels of certain categorical covariates. The practical use of this package is
illustrated using three real biomedical datasets.
Introduction
The classification of cases and controls is a common task in several fields. For example, it is con-
ducted in the atmospheric sciences (rainy/non rainy day), finance (good/not good payer), sociology
(good/not good citizen), industry (product of good/poor quality), computing science (spam/non-
spam) or health sciences (healthy/diseased), among others. However, in this paper we will focus
on the latter example, where we will be interested on the classification of individuals as healthy
or diseased using a continuous biomarker or diagnostic test that will be based on a cutoff point or
discrimination value c. If we suppose, without loss of generality, that high test values are associated
with the disease under study, individuals with a diagnostic test value equal to or higher than c are
classified as diseased (positive test) and individuals with a value lower than c are classified as healthy
(negative test). The test can classify a diseased patient incorrectly, that is, a false negative decision, or
detect a patient as diseased when his (or her) true status is healthy (a false positive misclassification).
So, for each cutoff point c, it is necessary to quantify these errors to check the validity of the diagnostic
test in clinical practice. In a similar way, the test can correctly classify a diseased patient (a true positive
decision) or a healthy patient (a true negative decision). For each cutpoint c, the sensitivity and
specificity measures of the accuracy of the diagnostic test can be defined from these correct decisions.
The sensitivity (Se) is the probability of a true positive decision, that is, the probability of correctly
classifying a diseased patient (true positive rate) and the specificity (Sp) is the probability of a true
negative decision (true negative rate), that is, the probability of correctly classifying a healthy individ-
ual. Similarly, the probabilities of the incorrect classifications are defined as 1− Se (false negative rate)
and 1− Sp (false positive rate).
Considering Se versus 1− Sp for all possible values of c, a curve is obtained. This curve is called
the Receiver Operating Characteristic (ROC) curve (Metz, 1978; Swets and Swets, 1979; Swets and
Pickett, 1982) and it is a graphical global measure of the diagnostic accuracy of a continuous diagnostic
test, independent of the cutpoint and the disease prevalence. In addition, it serves as a guide when
selecting optimal cutoffs and as a measure of the overlapping of the test values between healthy and
diseased populations. Numerical indexes defined from ROC curves are often used to summarize the
accuracy of a diagnostic test. For instance, the area under the curve (AUC) (Bamber, 1975; Swets,
1979) is the most commonly used and it takes values between 0.5 (the AUC value of an uninformative
test, the same as a random prediction) and 1 (the AUC value of a perfect test that classifies correctly
all individuals, either healthy or diseased). The AUC is equal to the Mann-Whitney U statistic for
comparing two distributions. Both of them can be interpreted as the probability that the diagnostic
value of a randomly chosen diseased individual will be higher than the diagnostic value of a randomly
chosen healthy one (Hanley and McNeil, 1982).
A key question in clinical practice is to find a cutpoint that “best” discriminates between patients
with and without the disease. However, one cannot talk in absolute terms of a “best choice”. This is
the reason why several criteria for selecting optimal cutpoints have been proposed in the literature
depending on the ultimate goal of such selection (see Youden, 1950; Feinstein, 1975; Metz, 1978; Schäfer,
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1989; Vermont et al., 1991; Greiner, 1995; Pepe, 2003, for example). One of the best-known methods is
based on selecting the cutpoint that provides the same value for the sensitivity and specificity. This
point is known as the equivalence or symmetry point (Greiner, 1995; Defreitas et al., 2004; Adlhoch
et al., 2011). Graphically, it corresponds with the operating point on the ROC curve that intersects
the perpendicular to the positive diagonal line, that is, y = 1− x, where x is the false positive rate.
The symmetry point can also be seen as the point that maximizes simultaneously both types of
correct classifications (Riddle and Stratford, 1999; Gallop et al., 2003), that is, it corresponds to the
probability of correctly classifying any subject, whether it is healthy or diseased (Jiménez-Valverde,
2012, 2014). Additionally, the incorporation of costs for the misclassification rates in the estimation
of optimal cutpoints is crucial for evaluating not only the test accuracy but also its clinical efficacy,
although this aspect is not taken into account most of the times. So, an interesting generalization of
the equivalence or symmetry point, cS, that takes into account the costs associated to the false positive
and false negative misclassifications, CFP and CFN , respectively, is the generalized equivalence point
or generalized symmetry point, cGS, that satisfies the following equation:
ρ(1− Sp(cGS)) = (1− Se(cGS)), (1)
where ρ = CFPCFN is the relative loss (cost) of a false-positive decision as compared with a false-negative
decision (see López-Ratón et al., 2016, for more details). Similarly to the symmetry point, this cost-
based generalization is obtained by intersecting the ROC curve and the line y = 1− ρx, where x is the
false positive rate. Obviously, when ρ = 1 in Equation 1, the generalized symmetry point yields the
traditional symmetry point. The reader can see some medical examples, that have taken into account
the misclassification costs in their ROC analysis, in the review conducted by Cantor et al. (1999) where
the Cost/Benefit (C/B) ratio is discussed (C/B= 1ρ ). Additionally, Subtil and Rabilloud (2015) include
some common values for the C/B ratio (C/B = 2, 5, 10, 100). High values of C/B ratio mean that it is
considered more harmful not to treat a diseased individual than to treat a healthy one.
Two statistical approaches have been recently introduced in the literature (López-Ratón et al.,
2016) to obtain point estimates and confidence intervals for the generalized symmetry point and its
associated sensitivity and specificity measures, a parametric method based on the Generalized Pivotal
Quantity (GPQ) under the assumption of normality (Weerahandi, 1993, 1995; Lai et al., 2012), and a
nonparametric method based on the Empirical Likelihood (EL) methodology without any parametric
assumptions (Thomas and Grunkemeier, 1975; Molanes-López and Letón, 2011).
The availability of software for estimating optimal cutpoints in a user-friendly environment
is very important and necessary for facilitating, mainly to the biomedical staff, the selection of
optimal cutpoints in clinical practice. There are several packages in R to carry out this task, such
as PresenceAbsence (Freeman and Moisen, 2008), DiagnosisMed (Brasil, 2010), pROC (Robin et al.,
2011) and OptimalCutpoints (López-Ratón and Rodríguez-Álvarez, 2014; López-Ratón et al., 2014).
However, these packages only consider the classical non-parametric empirical method for estimating
optimal cutpoints and accuracy measures, that is, none of them take into account recent methodology
introduced in ROC analysis such as the GPQ and EL approaches above-mentioned (Molanes-López
and Letón, 2011; Lai et al., 2012).
In this paper we present GsymPoint, a package written in R for estimating the generalized sym-
metry point (López-Ratón et al., 2017), which is freely available from the Comprehensive R Archive
Network (CRAN) at http://CRAN.R-project.org/package=GsymPoint. Specifically, this package en-
ables end-users to obtain point estimates and 100(1− α)% confidence intervals (with α the signification
level) for the cost-based generalization of the symmetry point, cGS, and its associated sensitivity and
specificity measures, Se(cGS) and Sp(cGS), by means of the two statistical approaches pointed out
above, the GPQ and EL approaches, that turn out to be more efficient than the empirical one. Therefore,
we take into account in the estimation process when normality can be assumed, and we consider one
of the most widely used criteria for selecting optimal cutpoints in clinical practice, the criterion that
generalizes the method where the sensitivity and specificity indexes are the same, taking into account
the misclassification costs, a very important issue when selecting the optimal cutpoint in a specific
clinical setting. In addition, since the test accuracy can be influenced by specific characteristics such as
the patient’s age or gender, or the disease severity (Pepe, 2003), the GsymPoint package allows the
computation of the generalized symmetry point for each level of a given categorical covariate. On one
hand, the numerical output of GsymPoint includes the generalized symmetry point and its associated
sensitivity and specificity indexes with their corresponding 100(1− α)% confidence intervals. On the
other hand, based on the graphical interpretation of the generalized symmetry point, the graphical
output shows the empirical ROC curve and the line y = 1− ρx.
The rest of paper is organized as follows. In Section 2.2, we briefly review the two methods
included in our GsymPoint package for obtaining point estimates and confidence intervals for the
generalized symmetry point and its sensitivity and specificity measures. In Section 2.3, we describe
the general use of this package, describing the most important functions. In Section 2.4, we illustrate
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the practical application of the package using three real biomedical datasets on melanoma, prostate
cancer, and coronary artery disease. Finally, in Section 2.5 we conclude with a discussion and some
interesting future extensions.
Generalized symmetry point estimating methods
In this section we briefly explain the two methods included in the GsymPoint package for estimating
and constructing confidence intervals for the generalized symmetry point cGS and its associated
accuracy measures Sp(cGS) and Se(cGS). To make inference on these parameters of interest, we









, taken from the healthy and diseased populations, Y0 and Y1, respectively,
with sample sizes n0 and n1.
Generalized pivotal quantity method
Generalized confidence intervals refer to a parametric methodology based on the normality assump-
tion, first introduced by Weerahandi (1993, 1995) and recently applied in the context of diagnostic
studies to the Youden index by Lai et al. (2012) and Zhou and Qin (2013), and to the generalized
symmetry point by López-Ratón et al. (2016).
Assuming that the diagnostic test in healthy and diseased populations Yi follows a normal dis-
tribution with mean µi and standard deviation σi, for i = 0, 1, it follows that the ROC curve has an
explicit expression:
ROC(x) = Φ(a + bΦ−1(x)), (2)
where a = µ1−µ0σ1 , b =
σ0
σ1
, x = 1− Sp(cS) and Φ denotes the standard normal cumulative distribution
function (cdf).
Therefore, under the normality assumption, using if necessary a monotone transformation of
Box-Cox type to achieve normality, it follows from Equations 1–2 that the generalized symmetry point
cGS can be estimated from the following equation:





− x = 0, (3)
replacing a and b by their sample versions ã = m1−m0s1 and b̃ =
s0
s1 , respectively, where mi and si denote
the sample mean and sample standard deviation of each population, for i = 0, 1. Once the root of
Equation 3 is obtained, x̃, then the parametric point estimates of cGS, Sp(cGS) and Se(cGS) are given
by c̃GS = m0 + s0Φ−1(1− x̃), S̃p(cGS) = 1− x̃ and S̃e(cGS) = 1− ρx̃, respectively.
For computing the GPQ-based confidence intervals of cGS, Sp(cGS) and Se(cGS), López-Ratón
et al. (2016) follow the same reasoning as in Lai et al. (2012), based on considering their corresponding
generalized pivotal quantities, that is, substituting a and b into Equation 3 with their generalized
pivotal values. For instance, if RcGS denotes the generalized pivotal quantity for estimating cGS,
and RcGS ,α denotes the αth quantile of the distribution of RcGS , then the corresponding 100(1− α)%
confidence interval for cGS based on its generalized pivotal quantity is given by the percentile method,
that is, by (RcGS ,α/2, RcGS ,1−α/2).
Empirical likelihood method
The empirical likelihood method was firstly introduced by Thomas and Grunkemeier (1975) that
proposed the construction of EL-based confidence intervals for the Kaplan-Meier estimator. Nowadays,
this methodology is an active area of research in several fields due to the good properties presented
by EL-based confidence intervals and regions (see, for example, Molanes-López et al., 2009, among
others). Moreover, this methodology has the advantages of easy implementation and not requiring any
particular parametric assumption. In the recent literature, Molanes-López and Letón (2011) proposed
a bootstrap-based EL approach to make inference on the Youden index and its associated optimal
cutpoint, and López-Ratón et al. (2016) applied these same bootstrap-based EL ideas for estimating and
constructing confidence intervals for the generalized symmetry point and its corresponding specificity
and sensitivity measures. The key point in both works is that the optimal cutpoint of int erest can be
seen as specific quantiles of the two populations involved.
As López-Ratón et al. (2016) mention, cGS can be seen as the Sp(cGS)-th quantile of the healthy
population and the ρ(1− Sp(cGS))-th quantile of the diseased population. Considering that the value
The R Journal Vol. 9/1, June 2017 ISSN 2073-4859
CONTRIBUTED RESEARCH ARTICLE 265
of Sp(cGS) is known in advance, they derive the following log-likelihood function to make inference
on the generalized symmetry point:
`(c) = −2 log(L(c))




































−∞ K(z)dz, K a kernel function and gi the corresponding smoothing parameter, for
i = 0, 1. Therefore, assuming that Sp(cGS) is known in advance, a nonparametric point estimate of
cGS could be found by minimizing `(c) over c, and a confidence interval for it could be obtained based
on the usual χ2 limiting distribution of `(c). However, taking into account the fact that Sp(cGS) is
unknown, López-Ratón et al. (2016) propose to estimate this parameter first by means of a kernel-
based method and then obtain a non-parametric point estimate of cGS by minimizing the previous
log-likelihood function, `(c), but where now the unknown parameter Sp(cGS) is replaced by its
estimate. Besides, they introduce a bootstrap-based EL approach that reproduces this procedure for
each pair of resamples taken independently from the two original samples and construct percentile
based confidence intervals from all the EL-based estimates previously calculated for those bootstrap
resamples.
The GsymPoint package
In this section we present GsymPoint, a package written in R for estimating the generalized symmetry
point (López-Ratón et al., 2017), which is freely available from the Comprehensive R Archive Network
(CRAN) at http://CRAN.R-project.org/package=GsymPoint. This package enables end-users to ob-
tain point estimates and 100(1− α)% confidence intervals using two recent methodologies introduced
in ROC analysis (Molanes-López and Letón, 2011; Lai et al., 2012) for the generalized symmetry point
and its corresponding sensitivity and specificity indexes. Specifically, the two estimating methods
presented in the previous section, the generalized pivotal quantity method (Weerahandi, 1993, 1995;
Lai et al., 2012; Zhou and Qin, 2013) and the empirical likelihood method (Thomas and Grunkemeier,
1975; Molanes-López and Letón, 2011) have been incorporated in a clear and user-friendly way for
the end-user. The GsymPoint package only requires a data-entry file where each column indicates
a variable and each row indicates an individual or patient. This dataset must, at least, contain the
variable with the diagnostic test values, the variable that indicates the true disease status (diseased
or healthy) and the variable with the levels of a categorical covariate of interest in case the optimal
cutpoint has to be computed for each level of that covariate. The numerical output of GsymPoint
package includes the generalized symmetry point and its corresponding sensitivity and specificity
indexes with their associated 100(1− α)% confidence intervals. In basis on the graphical interpretation
of the generalized symmetry point, the graphical output shows the intersection point between the
empirical ROC curve and the line y = 1− ρx, that is, an empirical estimate of the operating point
corresponding to the generalized symmetry point. Table 1 provides a summary of the most important
functions include d in the package.
The gsym.point() function
The main function of the package is the gsym.point() function, which uses the selected method(s)
(GPQ, EL or auto, where this last option automatically selects the most appropriate method based
on the normality assumption) to obtain (parametric and/or nonparametric) confidence intervals and
point estimates for cGS, Sp(cGS) and Se(cGS), and creates an object of class "gsym.point". The code to
use the gsym.point() function is as follows:
gsym.point(methods, data, marker, status, tag.healthy,
categorical.cov = NULL, control = control.gsym.point(),
CFN = 1, CFP = 1, confidence.level = 0.95,
trace = FALSE, seed = FALSE, value.seed = 3, verbose = TRUE)
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Function Description
gsym.point() Main function that computes the generalized sym-
metry point and its sensitivity and specificity mea-
sures with their corresponding confidence inter-
vals.
control.gsym.point() Used to set several parameters that control the esti-
mation process of the optimal cutpoint.
print() Print method for "gsym.point" class objects.
summary() Summary method for "gsym.point" class objects.
plot() Plot method for "gsym.point" class objects that
shows in the same graph the empirical ROC curve
and the line y = 1 − ρx. The intersection point
between them is an empirical estimate of the oper-
ating point associated to the optimal cutpoint given
by the generalized symmetry point.
Table 1: Most important functions included in the GsymPoint package.
The methods argument is a character vector to select the estimation method(s) to be used. The
possible options are: "GPQ","EL", c("GPQ","EL"), c("EL","GPQ") or "auto".
The data argument is the data frame containing all the needed variables: the diagnostic marker, the
true disease status and, when necessary, the categorical covariate; the marker and status arguments
are character strings with the names of the diagnostic test and the variable that distinguishes healthy
from diseased individuals, respectively. The value codifying healthy individuals in this last variable
status is indicated in the tag.healthy argument.
The categorical.cov argument is a character string with the name of the categorical covariate
according to which cGS is automatically computed for each of its levels. By default it is NULL, that is,
no categorical covariate is considered in the analysis.
The control argument indicates the output of the control.gsym.point() function, which controls
the whole calculation process. This function will be explained in detail in the following subsection.
The CFN and CFP arguments are the misclassification costs of false negative and false positive
classifications, respectively. The default value is 1 for both, that is, no misclassification costs are taking
into account by default.
The confidence.level argument is the numerical value of the confidence level 1− α considered
for the construction of confidence intervals. By default it is equal to 0.95.
The trace argument is a logical value that shows information on the calculation progress if TRUE.
By default it is FALSE.
The seed argument is a logical value, such that if TRUE, a seed is fixed for generating the trials
when computing the confidence intervals, allowing the reproducibility of the results at any other time.
The default value is FALSE.
The value.seed argument is the numerical value for the fixed seed if seed is TRUE. By default it is
equal to 3.
The verbose argument is a logical value that allows to show extra information on progress of
running. By default it is TRUE.
Some of these arguments, methods, data, marker, status and tag.healthy, are essential and must
be specified in the call to the gsym.point() function because, otherwise, an error is produced. The
other arguments, categorical.cov, control, confidence.level, trace, seed and value.seed, are
optional and, if they are not specified explicitly in the call, the values by default are taken.
The control.gsym.point() function
It should be noted that there are some extra arguments, specific to each estimation method. We
considered to include all of them in the control argument, which is a list of control values specified by
calling to the control.gsym.point() function, designed to replace the default values yielded by the
control.gsym.point() function. The arguments of the control.gsym.point() function are presented
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in Table 2.
Argument Description
B The number of simulations in the empirical likelihood
("EL") method. The default value is 499 based on Carpenter
and Bithell (2000).
c_sampling The constant needed for resampling in the empirical likeli-
hood ("EL") method. The default value is 0.25.
c_F The constant needed for estimating the distribution in the
empirical likelihood ("EL") method. The default value is
0.25.
c_ELq The constant needed for estimating the empirical likelihood
function in the empirical likelihood ("EL") method. The
default value is 0.25.
c_R The constant needed for estimating the ROC curve in the
empirical likelihood ("EL") method. The default value is
0.25.
I The number of replicates in the generalized pivotal quantity
("GPQ") method. The default value is 2500.
Table 2: Arguments of the control.gsym.point() function.
The summary.gsym.point() function
Numerical results are printed on the screen, and the output yielded by the summary.gsym.point()
function or the summary() method always includes:
• The matched call to the main function gsym.point().
• The estimated value of the area under the ROC curve (AUC) based on the Mann-Whitney U
statistic.
• Information related to the generalized symmetry point:
– The method(s) (EL and/or GPQ) used for estimating cGS, Sp(cGS) and Se(cGS).
– The point estimates and confidence intervals for cGS, Sp(cGS) and Se(cGS).
Apart from the matched call, that it is presented only once at the beginning, all the other information
will be shown for each level of the categorical covariate if this is specified in the call, that is, if the
categorical.cov argument in the gsym.point() function is not NULL.
The call to this function is as follows:
summary(object, ...)
where the object argument is a "gsym.point" class object as produced by the gsym.point() function
and the ellipsis ... indicate further arguments passed to or from other methods. None are used in
this method.
The plot.gsym.point() function
The graphical output of the GsymPoint package is yielded by the plot.gsym.point() function or by
the plot() method. This function plots the empirical ROC curve and the line y = 1− ρx. The call to
this function is as follows:
plot(x, legend = TRUE, ...)
where the x argument is a "gsym.point" class object as produced by the gsym.point() function, the
argument legend is a logical value for including the AUC value in the legend when it is TRUE (value
by default) and the ellipsis ... indicate further arguments passed to the plot.default() method.
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Practical application of GsymPoint package
This section illustrates the use of the R-based GsymPoint package by means of three real biomedical
datasets on melanoma, prostate cancer, and coronary artery disease.
Melanoma dataset
Dermatologists use a clinical scoring scheme without dermoscope (CSS) or a dermoscopic scoring
scheme (DSS) to clinically evaluate lesions on the skin on the basis of several visible features such as
asymmetry, border irregularity, colouration and size. We have considered a dataset on 72 patients
with suspicious lesions of being a melanoma (Venkatraman and Begg, 1996). Taking into account
that 21 melanomas were detected through biopsies, our objective here is to evaluate the capacity of
the CSS as a potential non-invasive diagnostic marker for discriminating between melanomas and
non-melanomas using the generalized symmetry point as the binary classification threshold. In the
following, we illustrate the use of the GsymPoint package for estimating that optimal threshold value.
The first step consists on attaching the GsymPoint package and the melanoma dataset as follows:
> library("GsymPoint")
> data("melanoma")
With the following instruction, we can get some basic summary statistics of the variables included
in the melanoma dataset:
> summary(melanoma)
X group
Min. :-5.88100 Min. :0.0000
1st Qu.:-3.22100 1st Qu.:0.0000
Median :-1.69550 Median :0.0000
Mean :-1.55642 Mean :0.2917
3rd Qu.: 0.00675 3rd Qu.:1.0000
Max. : 3.03200 Max. :1.0000
To estimate the generalized symmetry point of the CSS marker, we need to call the gsym.point()
function. For instance, as specified below.
> melanoma.cutpoint1 <- gsym.point(methods = "GPQ", data = melanoma,
+ marker = "X", status = "group", tag.healthy = 0,
+ categorical.cov = NULL, CFN = 2, CFP = 1,
+ control = control.gsym.point(), confidence.level = 0.95,
+ trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
In this call, we have considered that a false negative decision is 2 times more serious than a false
positive decision, and so we have set CFN = 2 and CFP = 1 for the misclassification costs. Besides,
we have considered the GPQ method of estimation (methods = "GPQ") because, according to the
Shapiro-Wilk normality test, the CSS values can be assumed normally distributed in both melanoma
and non-melanoma groups, and under this assumption the GPQ method is more adequate than the
EL method in this case.
The melanoma.cutpoint1 object produced by this call is a list that consists of the following compo-
nents: "GPQ", "methods", "call", and "data", as can be checked below with the names command:
> names(melanoma.cutpoint1)
[1] "GPQ" "methods" "call" "data"
The last three components, "methods", "call" and "data" are, respectively, a character vector with
the value of the argument methods used in the call, the matched call, and the data frame used in the
analysis. The first component, "GPQ", contains the results provided by the GPQ method regarding the




[1] "optimal.result" "AUC" "rho"
[4] "pvalue.healthy" "pvalue.diseased"
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1 -1.213237 -1.792908 -0.6283236
$Global$optimal.result$Specificity
Value ll ul
1 0.75465 0.6249716 0.8485824
$Global$optimal.result$Sensitivity
Value ll ul









The "optimal.result" component is a list with the point estimates and 100(1− α)% confidence
intervals of the generalized symmetry point and its associated sensitivity and specificity accuracy
measures, "AUC" is the numerical value of the area under the ROC curve, "rho" is the numerical value
of the costs ratio ρ = CFPCFN , "pvalue.healthy" is the p-value of the Shapiro-Wilk normality test used to
check the normality assumption of the marker in the healthy population, and "pvalue.diseased" is
the p-value of the Shapiro-Wilk normality test used to check the normality assumption in the diseased
population.
The end-user can directly access each of these components. For example, the following instruction
only yields the value of the AUC:
> melanoma.cutpoint1$GPQ$Global$AUC
[1] 0.9056956
A numerical summary of the results can be obtained by means of the print.gsym.point() or
summary.gsym.point() functions, which can be abbreviated by the print() and summary() methods,
respectively, as can be seen below:
> summary(melanoma.cutpoint1)
*************************************************
OPTIMAL CUTOFF: GENERALIZED SYMMETRY POINT
*************************************************
Call:
gsym.point(methods = "GPQ", data = melanoma, marker = "X", status = "group",
tag.healthy = 0, categorical.cov = NULL, CFN = 2, CFP = 1,
control = control.gsym.point(), confidence.level = 0.95,
trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
According to the Shapiro-Wilk normality test, the marker can be
considered normally distributed in both groups.
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.4719 0.9084
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Area under the ROC curve (AUC): 0.906
METHOD: GPQ
Estimate 95% CI lower limit 95% CI upper limit
cutoff -1.213237 -1.7929079 -0.6283236
Specificity 0.754650 0.6249716 0.8485824
Sensitivity 0.877325 0.8124858 0.9242912
As seed = TRUE in the previous call, the user can replicate the output by simply running again the
same call.
In this case, as can be seen above, the output provided by the summary.gsym.point() function
shows:
1. An informative message indicating that the marker can be considered normally distributed in
both groups, according to the Shapiro-Wilk normality test.
2. The Shapiro-Wilk test p-values indicating normality in both groups.
3. The AUC value and information related to the generalized symmetry point, that is, the point
estimates and the GPQ based 100(1− α)% confidence intervals for the generalized symmetry
point and its corresponding sensitivity and specificity indexes. By default, confidence intervals
are computed with a default confidence level, 1− α, equal to 95%, although a different value
can be set in the confidence.level argument of the main gsym.point() function.
So far, we have considered the GPQ method that, under normality assumptions, turns out to be
more appropriate than the EL method. As you can see below, if we now replace the GPQ method
by the EL method in the call, the program shows in the first place an informative message on the
normality assumption and the better appropriateness of the GPQ method.
> melanoma.cutpoint2 <- gsym.point(methods = "EL", data = melanoma,
+ marker = "X", status = "group", tag.healthy = 0,
+ categorical.cov = NULL, CFN = 2, CFP = 1,
+ control = control.gsym.point(), confidence.level = 0.95,
+ trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
According to the Shapiro-Wilk normality test, the marker can be
considered normally distributed in both groups.
Therefore the GPQ method would be more suitable for this dataset.
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.4719 0.9084
By means of the summary() function, we show below the results obtained with the EL method. In
this case, after reproducing the call used to create the melanoma.cutpoint2 object, the same informative
message is shown regarding the better appropriateness of the GPQ method to this dataset.
> summary(melanoma.cutpoint2)
*************************************************
OPTIMAL CUTOFF: GENERALIZED SYMMETRY POINT
*************************************************
Call:
gsym.point(methods = "EL", data = melanoma, marker = "X", status = "group",
tag.healthy = 0, categorical.cov = NULL, CFN = 2, CFP = 1,
control = control.gsym.point(), confidence.level = 0.95,
trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
According to the Shapiro-Wilk normality test, the marker can be
considered normally distributed in both groups.
Therefore the GPQ method would be more suitable for this dataset.
Shapiro-Wilk test p-values
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Group 0 Group 1
Original marker 0.4719 0.9084
Area under the ROC curve (AUC): 0.906
METHOD: EL
Estimate 95% CI lower limit 95% CI upper limit
cutoff -1.2382325 -1.8403497 -0.4565671
Specificity 0.7901833 0.6326184 0.8973174
Sensitivity 0.8950916 0.8163092 0.9486587
Since both estimating methods are adequate for this dataset, we could specify them simultaneously
in the call to the gsym.point() function as follows.
> melanoma.cutpoint3 <- gsym.point(methods = c("EL","GPQ"),
+ data = melanoma, marker = "X", status = "group",
+ tag.healthy = 0, categorical.cov = NULL, CFN = 2, CFP = 1,
+ control = control.gsym.point(), confidence.level = 0.95,
+ trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
According to the Shapiro-Wilk normality test, the marker can be
considered normally distributed in both groups.
Therefore, although the results of both methods will be shown,
the GPQ method would be more suitable for this dataset.
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.4719 0.9084
With the option methods = "auto" the program selects in this case the GPQ method based on the
normality assumption satisfied for this dataset.
The graphical output of any of the three objects previously created, can be obtained by means of
the plot.gsym.point() function, which can be abbreviated by the plot() method.


























● GPQ: (0.245, 0.877)
AUC:  0.906
Figure 1: Graphical output for the melanoma dataset.
For instance, the call below
> plot(melanoma.cutpoint1)
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shows the plot of the empirical Receiver Operating Characteristic (ROC) curve, the line y = 1− ρx, and
the intersection point between them, that is, an empirical estimate of the operating point associated
to the generalized symmetry point of the CSS marker for discriminating between patients with and
without melanoma. Although this is the default output (see Figure 1), the end-user can add specific
graphic parameters, such as color, legend, etc.
Prostate cancer dataset
We have considered here the dataset on prostate cancer analyzed by Le (2006). In order to design an
appropriate treatment strategy for a patient with prostate cancer, it is important to know first whether
cancer has spread or not to the neighboring lymph nodes. Although a laparoscopic surgery could
confirm the true status of the patient, it is interesting to find a non-invasive diagnostic method to
predict whether nodal involvement is present or not. In this dataset, 20 patients (of the total of 55
patients) had nodal involvement, and the level of acid phosphatase in blood serum (APBS) (×100)
was considered as the diagnostic marker for predicting nodal involvement. We illustrate below how
to apply the GsymPoint package for estimating the generalized symmetry point of the APBS marker
that will be used for discriminating between individuals with and without nodal involvement.
As shown below, after loading the Gsympoint package and the prostate cancer dataset, we use
the gsym.point() function to estimate the generalized symmetry point of the APBS marker and its
associated specificity and sensitivity indexes.
> library("GsymPoint")
> data("prostate")
> prostate.cutpoint1 <- gsym.point(methods = "GPQ", data = prostate,
+ marker = "marker", status = "status", tag.healthy = 0,
+ categorical.cov = NULL, CFN = 10, CFP = 1,
+ control = control.gsym.point(I = 1500), confidence.level = 0.95,
+ trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
Since cancer is a very serious disease which can cause death, a FN result in this biomedical ex-
ample is much more harmful than a FP result. Specifically, we have considered that a false negative
classification is exactly 10 times more serious than a false positive classification (CFN = 10, CFP =
1). Since the Shapiro-Wilk normality test indicated that both groups could be assumed normally
distributed (after a Box-Cox transformation of the data), the GPQ method is more adequate than the
EL method in this case. For the sake of illustration, we have changed the default value of the number
of replicates associated to the GPQ method by setting control = control.gsym.point(I = 1500) in
the call to the gsym.point() function. The default value for this parameter is I = 2500.
Below we show the numerical results obtained by means of the summary.gsym.point() function,
which can be abbreviated by the summary() method:
> summary(prostate.cutpoint1)
*************************************************
OPTIMAL CUTOFF: GENERALIZED SYMMETRY POINT
*************************************************
Call:
gsym.point(methods = "GPQ", data = prostate, marker = "marker",
status = "status", tag.healthy = 0, categorical.cov = NULL,
CFN = 10, CFP = 1, control = control.gsym.point(I = 1500),
confidence.level = 0.95, trace = FALSE, seed = TRUE, value.seed = 3,
verbose = TRUE)
According to the Shapiro-Wilk normality test, the marker can not
be considered normally distributed in both groups.
However, after transforming the marker using the Box-Cox
transformation estimate, the Shapiro-Wilk normality test
indicates that the transformed marker can be considered
normally distributed in both groups.
Box-Cox lambda estimate = -1.2494
Shapiro-Wilk test p-values
The R Journal Vol. 9/1, June 2017 ISSN 2073-4859
CONTRIBUTED RESEARCH ARTICLE 273
Group 0 Group 1
Original marker 0.0000 0.0232
Box-Cox transformed marker 0.3641 0.2118
Area under the ROC curve (AUC): 0.725
METHOD: GPQ
Estimate 95% CI lower limit 95% CI upper limit
cutoff 51.9522523 46.8013315 57.3009307
Specificity 0.3233012 0.1420636 0.5191686
Sensitivity 0.9323301 0.9142064 0.9519169
In this case, the numerical output obtained with the summary.gsym.point() function shows:
1. An informative message indicating that the original data can not be assumed normally dis-
tributed in both groups, but the Box-Cox transformed data can be considered normally dis-
tributed in both groups, according to the Shapiro-Wilk normality test.
2. The estimated value of the Box-Cox power lambda.
3. The estimated value of the area under the ROC curve (AUC).
4. Information corresponding to the generalized symmetry point: the point estimates and the
GPQ based 100(1− α)% confidence intervals (where α is the signification level) of the gener-
alized symmetry point in the scale of the APBS marker and its corresponding sensitivity and
specificity measures. By default, confidence intervals are computed for a confidence level 1− α
of 0.95. However, this value can be changed in the confidence.level argument of the main
gsym.point() function.
As can be checked with the command below, the prostate.cutpoint1 object yields a list with the
following components: "GPQ", "methods", "call", and "data".
> names(prostate.cutpoint1)
[1] "GPQ" "methods" "call" "data"









The "methods" component is a character vector with the value of the argument methods used in




gsym.point(methods = "GPQ", data = prostate, marker = "marker",
status = "status", tag.healthy = 0, categorical.cov = NULL,
CFN = 10, CFP = 1, control = control.gsym.point(I = 1500),
confidence.level = 0.95, trace = FALSE,
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We list below the elements of the first component, "GPQ", of the prostate.cutpoint1 object and
show the corresponding R-based commands that allow end-users to directly access these elements:
1. "optimal.result" is a list with the generalized symmetry point and its sensitivity and specificity




1 51.95225 46.80133 57.30093
$Specificity
Value ll ul
1 0.3233012 0.1420636 0.5191686
$Sensitivity
Value ll ul
1 0.9323301 0.9142064 0.9519169
2. "AUC" is the numerical value of the area under the ROC curve.
> prostate.cutpoint1$GPQ$Global$AUC
[1] 0.725
3. "rho" is the numerical value of ρ = CFP/CFN (in this case ρ = 0.1).
> prostate.cutpoint1$GPQ$Global$rho
[1] 0.1




5. "normality.transformed" is a character string indicating if the transformed marker values by
the Box-Cox transformation are normally distributed ("yes") or not ("no").
> prostate.cutpoint1$GPQ$Global$normality.transformed
[1] "yes"
6. "pvalue.healthy" is the numerical value of the p-value obtained by the Shapiro-Wilk normality
test for checking the normality assumption of the marker in the healthy population.
> prostate.cutpoint1$GPQ$Global$pvalue.healthy
[1] 3.276498e-07
7. "pvalue.diseased" is the numerical value of the p-value obtained by the Shapiro-Wilk normal-
ity test for checking the normality assumption of the marker in the diseased population.
> prostate.cutpoint1$GPQ$Global$pvalue.diseased
[1] 0.02323895
8. "pvalue.healthy.transformed" is the numerical value of the p-value obtained by the Shapiro-
Wilk normality test for checking the normality assumption of the Box-Cox transformed marker
in the healthy population.
> prostate.cutpoint1$GPQ$Global$pvalue.healthy.transformed
[1] 0.3640662
9. "pvalue.diseased.transformed" is the numerical value of the p-value obtained by the Shapiro-
Wilk normality test for checking the normality assumption of the Box-Cox transformed marker
in the diseased population.
> prostate.cutpoint1$GPQ$Global$pvalue.diseased.transformed
[1] 0.2118137
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Similarly to the previous example, if we now consider the EL method instead of the GPQ method
for estimating the generalized symmetry point and its accuracy measures, an informative message is
shown by the package, advising the user that the GPQ method is more suitable for this dataset due to
the fact that the Box-Cox transformed marker can be assumed normally distributed in both groups.
> prostate.cutpoint2 <- gsym.point(methods = "EL", data = prostate,
+ marker = "marker", status = "status", tag.healthy = 0,
+ categorical.cov = NULL, CFN = 10, CFP = 1,
+ control = control.gsym.point(B = 999), confidence.level = 0.95,
+ trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
According to the Shapiro-Wilk normality test, the marker can not
be considered normally distributed in both groups.
However, after transforming the marker using the Box-Cox
transformation estimate, the Shapiro-Wilk normality test
indicates that the transformed marker can be considered
normally distributed in both groups.
Therefore the GPQ method would be more suitable for this dataset.
Box-Cox lambda estimate = -1.2494
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.0000 0.0232
Box-Cox transformed marker 0.3641 0.2118
For the sake of illustration, we have set control = control.gsym.point(B = 999) in the previous
call to change the default value of the number of bootstrap replicates B required in the empirical
likelihood method. This parameter is B = 499 by default.
The results obtained with the EL method are the following.
> summary(prostate.cutpoint2)
*************************************************
OPTIMAL CUTOFF: GENERALIZED SYMMETRY POINT
*************************************************
Call:
gsym.point(methods = "EL", data = prostate, marker = "marker",
status = "status", tag.healthy = 0, categorical.cov = NULL,
CFN = 10, CFP = 1, control = control.gsym.point(B = 999),
confidence.level = 0.95, trace = FALSE, seed = TRUE, value.seed = 3,
verbose = TRUE)
According to the Shapiro-Wilk normality test, the marker can not
be considered normally distributed in both groups.
However, after transforming the marker using the Box-Cox
transformation estimate, the Shapiro-Wilk normality test
indicates that the transformed marker can be considered
normally distributed in both groups.
Therefore the GPQ method would be more suitable for this dataset.
Box-Cox lambda estimate = -1.2494
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.0000 0.0232
Box-Cox transformed marker 0.3641 0.2118
Area under the ROC curve (AUC): 0.725
METHOD: EL
Estimate 95% CI lower limit 95% CI upper limit
cutoff 49.2249839 45.39058266 58.7032623
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Specificity 0.2451690 0.09891113 0.5269153
Sensitivity 0.9245169 0.90989111 0.9526915
Figure 2 shows the graphical output corresponding to any of the two "gsym.point" class objects
previously created, prostate.cutpoint1 and prostate.cutpoint2, as generated by means of the
plot() method. For instance, the code below produces Figure 2.
> plot(prostate.cutpoint1)


























● GPQ: (0.677, 0.932)
AUC:  0.725
Figure 2: Graphical output for the prostate cancer dataset.
Coronary artery disease dataset
We now consider a study conducted on 141 patients (96 with coronary lesions and 45 with non-stenotic
coronaries) admitted to the cardiology department of a teaching hospital in Galicia (Northwest Spain)
for evaluating chest pain or cardiovascular disease, where the leukocyte elastase determination was
investigated as a potential clinical marker for the diagnosis of coronary artery disease (Amaro et al.,
1995). Since in this biomedical example there is available information regarding the gender of the
patient (female or male), we will illustrate the practical application of the GsymPoint package to
these data taking into account the covariate gender, that is, the generalized symmetry point will be
computed for each gender in the scale of the elastase concentration to diagnose coronary artery disease
(CAD). From here on, we will refer to this dataset as elastase.
First of all, we need to load the GsymPoint package and the corresponding elastase dataset:
> library("GsymPoint")
> data("elastase")
Now, for computing the generalized symmetry point in the elastase scale taking into account
the categorical covariate gender, we simply have to include categorical.cov = "gender" in the call
below.
> elastase.gender.cutpoint1 <- gsym.point(methods = "GPQ",
+ data = elastase, marker = "elas", status = "status",
+ tag.healthy = 0, categorical.cov = "gender", CFN = 10, CFP = 1,
+ control = control.gsym.point(), confidence.level = 0.95,
+ trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
In this case we are interested in having a high sensitivity, that is, a low number of false negatives.
Therefore, the same values as in the previous prostate cancer dataset were considered for the misclas-
sification costs, CFN = 10 and CFP = 1, that is, a false negative result is regarded as 10 times more
serious than a false positive one. Since the elastase concentration in females and males follow the
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Box-Cox family in both CAD and non-CAD groups according to the Shapiro-Wilk normality test, the
GPQ method of estimation is more adequate than the EL method in this case.
The elastase.gender.cutpoint1 object produced by the previous call is a list with the following
components:
> names(elastase.gender.cutpoint1)
[1] "GPQ" "methods" "levels.cat" "call"
[5] "data"
Similarly to the previous datasets, the "methods" component is a character vector with the value of
the argument methods used in the call, "call" is the matched call and "data" is the data frame used in
the analysis. However, now there is an extra component, "levels.cat", a character vector indicating
the levels of the categorical covariate ("Female" and "Male" in this case). Besides, the first component,
"GPQ", that includes the results associated with the GPQ method is itself a two-component list with
"Female" and "Male" as can be seen below.
> names(elastase.gender.cutpoint1$GPQ)
[1] "Female" "Male"
For each level of the categorical covariate, you get a list with nine components. For instance, for







The "optimal.result" component of elastase.gender.cutpoint1$GPQ$Male is a list with the
point estimates and 100(1− α)% confidence intervals of the generalized symmetry point in the scale
of the elastase concentration and its associated sensitivity and specificity accuracy measures in the




1 20.72776 18.08961 23.49228
$Specificity
Value ll ul
1 0.2739826 0.1345484 0.4326794
$Sensitivity
Value ll ul
1 0.9273983 0.9134548 0.9432679
The "AUC" component of elastase.gender.cutpoint1$GPQ$Male is the numerical value of the area
under the ROC curve for the subgroup of individuals that are males.
> elastase.gender.cutpoint1$GPQ$Male$AUC
[1] 0.7216855
The "rho" component of elastase.gender.cutpoint1$GPQ$Male is the numerical value of the
ratio ρ = CFPCFN , which is the same for females and males.
> elastase.gender.cutpoint1$GPQ$Male$rho
[1] 0.1
The "lambda" component of elastase.gender.cutpoint1$GPQ$Male is the estimated numerical
value of the power in the Box-Cox transformation obtained when considering only the subgroup of
individuals that are males.
> elastase.gender.cutpoint1$GPQ$Male$lambda
[1] -0.04277911
The "normality.transformed" component of elastase.gender.cutpoint1$GPQ$Male is a charac-
ter string indicating if the Box-Cox transformed marker values in the subgroup of males are normally
distributed ("yes") or not ("no").
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> elastase.gender.cutpoint1$GPQ$Male$normality.transformed
[1] "yes"
The "pvalue.healthy" component of elastase.gender.cutpoint1$GPQ$Male is the p-value of the




The "pvalue.diseased" component of elastase.gender.cutpoint1$GPQ$Male is the p-value of




Similarly, the "pvalue.healthy.transformed" and "pvalue.diseased.transformed" components
are the p-values of the Shapiro-Wilk normality test used to check the normality assumption of the





A summary of the numerical results is shown bellow. In this case, the results obtained are shown
for each level of the categorical covariate gender, that is, for females and males. However, similarly
to previous examples, the output shows first the AUC value and then information related to the
generalized symmetry point (point estimates and 100(1 − α)% confidence intervals obtained for
each method of estimation specified in the main gsym.point() function). By default, confidence
intervals are computed for a confidence level 1-α of 0.95, but this value can be changed directly in the
confidence.level argument of the gsym.point() function.
> summary(elastase.gender.cutpoint1)
*************************************************
OPTIMAL CUTOFF: GENERALIZED SYMMETRY POINT
*************************************************
Call:
gsym.point(methods = "GPQ", data = elastase, marker = "elas",
status = "status", tag.healthy = 0, categorical.cov = "gender",
CFN = 10, CFP = 1, control = control.gsym.point(), confidence.level = 0.95,




According to the Shapiro-Wilk normality test, the marker can be
considered normally distributed in both groups.
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.0837 0.9077
Area under the ROC curve (AUC): 0.818
METHOD: GPQ
Estimate 95% CI lower limit 95% CI upper limit
cutoff 25.0929510 12.3370641 34.0526540
Specificity 0.4246091 0.1460251 0.6618634
Sensitivity 0.9424609 0.9146025 0.9661863
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According to the Shapiro-Wilk normality test, the marker can not
be considered normally distributed in both groups.
However, after transforming the marker using the Box-Cox
transformation estimate, the Shapiro-Wilk normality test
indicates that the transformed marker can be considered
normally distributed in both groups.
Box-Cox lambda estimate = -0.0428
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.5867 0.0000
Box-Cox transformed marker 0.0666 0.2147
Area under the ROC curve (AUC): 0.722
METHOD: GPQ
Estimate 95% CI lower limit 95% CI upper limit
cutoff 20.7277556 18.0896126 23.4922813
Specificity 0.2739826 0.1345484 0.4326794
Sensitivity 0.9273983 0.9134548 0.9432679
If we consider now the EL method in the call to the main gsym.point() function, the GsymPoint
package will show an informative message indicating that the GPQ method would be more adequate
in this case because for the two levels of the categorical covariate gender, either the original marker or
the Box-Cox transformed marker in both diseased and healthy populations can be assumed normally
distributed according to the Shapiro-Wilk normality test:
> elastase.gender.cutpoint2 <- gsym.point (methods = "EL", data = elastase,
+ marker = "elas", status = "status", tag.healthy = 0,
+ categorical.cov = "gender", CFN = 10, CFP = 1,
+ control = control.gsym.point(), confidence.level = 0.95,
+ trace = FALSE, seed = TRUE, value.seed = 3, verbose = TRUE)
Female :
According to the Shapiro-Wilk normality test, the marker can be
considered normally distributed in both groups.
Therefore the GPQ method would be more suitable for this dataset.
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.0837 0.9077
Male :
According to the Shapiro-Wilk normality test, the marker can not
be considered normally distributed in both groups.
However, after transforming the marker using the Box-Cox
transformation estimate, the Shapiro-Wilk normality test
indicates that the transformed marker can be considered
normally distributed in both groups.
Therefore the GPQ method would be more suitable for this dataset.
Box-Cox lambda estimate = -0.0428
Shapiro-Wilk test p-values
Group 0 Group 1
Original marker 0.5867 0.0000
Box-Cox transformed marker 0.0666 0.2147
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● GPQ: (0.575, 0.942)
AUC:  0.818


























● GPQ: (0.726, 0.927)
AUC:  0.722
Figure 3: Graphical output for the coronary artery disease dataset, distinguishing by gender.
The graphical results can be obtained by means of the plot.gsym.point() function or merely the
plot() method. For instance, the following command
> plot(elastase.gender.cutpoint1)
yields the graphical output shown in Figure 3, where the empirical ROC curve of the elastase con-
centration is represented separately for females and males, together with the line y = 1− ρx and
the intersection point associated to the generalized symmetry point for detecting CAD. This is the
output that appears by default for females and males, respectively. However, as usual, the end-user
can change several graphical parameters, such as legends, colors, etc.
Discussion
The selection of optimal cutpoints in the scale of a quantitative diagnostic test or biomarker that can
help in the diagnosis of a disease is an important issue in the clinical sciences. Depending on the
main objective of such selection, several criteria of optimality have been proposed in the literature to
carry out this task. One of the most popular in clinical practice is based on selecting the cutoff that
provides the same sensitivity and specificity, known in the literature as the equivalence or symmetry
point (Greiner, 1995; Defreitas et al., 2004; Adlhoch et al., 2011). However, this cutpoint is not valid
in scenarios where the severity of misclassifying a diseased patient is not the same as the severity
of misclassifying a healthy patient, which is normally the case in practice. For instance, in cancer
disease, a false negative decision is in general more serious than a false positive decision. Hence,
when selecting an optimal cutpoint it is very important to take into account the costs of the different
incorrect diagnostic decisions. For this reason, the generalized symmetry point, a generalization of the
symmetry point that incorporates the costs of the misclassifications is very adequate and useful in
practice (López-Ratón et al., 2016). Although there are several R packages that implement different
criteria for selecting the optimal cutoff point such as PresenceAbsence (Freeman and Moisen, 2008),
DiagnosisMed (Brasil, 2010), pROC (Robin et al., 2011) and OptimalCutpoints (López-Ratón and
Rodríguez-Álvarez, 2014; López-Ratón et al., 2014), up to our knowledge, none of them includes the
criterion based on the generalized symmetry point nor recent estimation approaches such as the GPQ
and EL methods that provide more efficient estimates than the empirical ones (Molanes-López and
Letón, 2011; Lai et al., 2012). In order to avoid that the use of the generalized symmetry point is limited
in the clinical practice by the lack of software that implements all necessary computations to estimate
it, we have developed the Gsympoint package, a user-friendly R package that fills this gap. As it
has been illustrated in this paper, the GsymPoint package allows the possibility that the generalized
symmetry point is straightforwardly estimated for each level of a certain categorical covariate that
represents an individual characteristic such as gender, age or disease severity, and that may influence
the discrimination capacity of the diagnostic test (Pepe, 2003). Possible interesting extensions of the
GsymPoint package could be taken into account. For instance, the implementation of this same
methodology to estimate other accuracy measures such as predictive values or diagnostic likelihood
ratios, the incorporation of more efficient methods for estimating the generalized symmetry point
and its accuracy measures, and the extension of this methodology to other more complex scenarios
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where, for instance, the diagnostic test is subject to the measurement of error, there is presence of
partial disease verification (see Alonzo, 2014, and references therein), the disease status evolves over
time and the disease onset time is subject to censoring (Rota et al., 2015) or there are continuous
covariates available that may affect the diagnostic capacity of the biomarker and that should be taken
into consideration.
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